Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.24.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 38,415,549 $ 4,212 $ 68,229,024   $ (29,817,687)
Beginning balance, Shares at Dec. 31, 2021   4,212,317      
Stock-based compensation expense 458,147   458,147    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   11,977      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 111,142 $ 12 111,130    
Other comprehensive income 104,718     $ 104,718  
Net loss (18,054,155)       (18,054,155)
Ending balance at Dec. 31, 2022 $ 21,035,401 $ 4,224 68,798,301 104,718 (47,871,842)
Ending balance, Shares at Dec. 31, 2022 4,224,294 4,224,294      
Stock-based compensation expense $ 500,148   500,148    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   1,961,986      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 8,575,097 $ 1,962 8,573,135    
Other comprehensive income (103,841)     (103,841)  
Net loss (19,028,883)       (19,028,883)
Ending balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 $ 77,871,584 $ 877 $ (66,900,725)
Ending balance, Shares at Dec. 31, 2023 6,186,280 6,186,280